Citadel Advisors’s Stoke Therapeutics STOK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$4.01M Buy
123,022
+107,171
+676% +$3.51M ﹤0.01% 4708
2025
Q4
$503K Sell
15,851
-58,205
-79% -$1.75M ﹤0.01% 9003
2025
Q3
$1.74M Sell
74,056
-29,188
-28% -$500K ﹤0.01% 6361
2025
Q2
$1.17M Sell
103,244
-4,318
-4% -$41K ﹤0.01% 6734
2025
Q1
$715K Buy
107,562
+14,982
+16% +$140K ﹤0.01% 7700
2024
Q4
$1.02M Buy
92,580
+85,630
+1,232% +$1.05M ﹤0.01% 6967
2024
Q3
$85.4K Buy
+6,950
New +$98.4K ﹤0.01% 11325
2024
Q1
Sell
-15,577
Closed -$94.4K 15410
2023
Q4
$81.9K Sell
15,577
-60,543
-80% -$259K ﹤0.01% 11190
2023
Q3
$300K Sell
76,120
-96,178
-56% -$632K ﹤0.01% 9171
2023
Q2
$1.83M Sell
172,298
-52,167
-23% -$555K ﹤0.01% 5299
2023
Q1
$1.87M Sell
224,465
-85,041
-27% -$767K ﹤0.01% 5527
2022
Q4
$2.86M Buy
309,506
+37,725
+14% +$392K ﹤0.01% 4834
2022
Q3
$3.49M Buy
271,781
+146,544
+117% +$2.34M ﹤0.01% 4506
2022
Q2
$1.65M Sell
125,237
-3,295
-3% -$50.1K ﹤0.01% 5940
2022
Q1
$2.71M Buy
128,532
+120,110
+1,426% +$2.41M ﹤0.01% 5422
2021
Q4
$202K Sell
8,422
-20,945
-71% -$500K ﹤0.01% 11835
2021
Q3
$747K Sell
29,367
-29,765
-50% -$830K ﹤0.01% 8885
2021
Q2
$1.99M Buy
59,132
+26,802
+83% +$947K ﹤0.01% 6634
2021
Q1
$1.26M Buy
+32,330
New +$1.84M ﹤0.01% 7538
2020
Q2
Sell
-18,865
Closed -$432K 10473
2020
Q1
$432K Buy
18,865
+8,400
+80% +$208K ﹤0.01% 6711
2019
Q4
$296K Buy
+10,465
New +$263K ﹤0.01% 7603
2019
Q3
Sell
-99,818
Closed -$2.91M 9732
2019
Q2
$2.91M Buy
+99,818
New +$2.68M ﹤0.01% 3906

Other funds holding STOK